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Objective: US long-haul truck drivers experience a wide array of excess
cardiometabolic disease (CMD) risks unique to their occupation. How these
risks translate to, and potentially induce, elevations in the clinical CMD risk
profile of this population is unknown. Methods: A non-experimental, descrip-
tive, cross-sectional design was employed to collect anthropometric and
biometric data from 115 long-haul truckers to generate for the first time a
comprehensive CMD risk marker profile, which was then compared with the
general US population. The relationships between CMD risk markers and
CMD outcomes were examined for both populations. Results: The long-haul
trucker sample presented elevated CMD risk markers, generally scoring
significantly worse than the general population. Associations between
CMD risk markers and disease states varied between both populations.
Conclusions: US long-haul truck drivers’ distinctive CMD risk profile
indicates occupationally-linked CMD pathogenesis.
C ardiometabolic disease (CMD) risk refers to the presence of adiverse set of indicators that are linked to cardiovascular and
metabolic disease outcomes. Multiple markers may be utilized to
assess CMD risk, but metabolic syndrome represents a cluster of
clearly defined, specific risk factors: while each of these risk factors
has an independent effect on CMD risk, they also function synerg-
istically to elevate such risk.1,2 Metabolic syndrome is diagnosed if
subjects meet three or more of the following five criteria: abdominal
obesity (waist circumference 102 cm for men and 89 cm for
women); high triglycerides (150 mg/dL for men and women); low
high-density lipoprotein (HDL) cholesterol (<40 mg/dL for men
and<50 mg/dL for women); high blood pressure (130/85 for men
and women); and high glucose (100 mg/dL for men and women).3
Obesity has been well established as a risk marker for CMD.4
Novel measures of body composition that assess abdominal deposits
of adiposity are associated with hypertension, diabetes, and car-
diovascular disease.2,4 Abdominal obesity is commonly measured
non-invasively by waist circumference (WC) or sagittal abdominal
diameter (SAD).5,6 Blood pressure and blood lipids constitute
traditional CMD risk markers.1,7,8 Blood glucose levels may
indicate type 2 diabetes mellitus, itself associated with cardiovas-
cular disease risk.9 Finally, CMD risk markers may indicate
systemic low-grade inflammation associated with obesity. Due to
its impact on the inflammatory system, obesity generates a system-
atic inflammatory response.2 At the cellular level, obesity results in
adipocyte hypertrophy, which can induce hypoxia and cellular
apoptosis and shift the macrophage phenotype of adipose tissue
from anti-inflammatory to pro-inflammatory.10 This transition in
macrophage phenotype induces the production of cytokines such as
Interleukin-6 (IL-6).5 Chronic elevations in IL-6 that occur with
inflammation are associated with elevated CRP levels.5,11 Systemic
low-grade inflammation has been hypothesized to be the linkage
between obesity and CMD outcomes.5,10–12
In the US, cardiometabolic health is generally poor. Heart
disease, one CMD outcome, is the leading cause of death.13 Type 2
diabetes mellitus, another CMD outcome, has steadily increased in
prevalence over the past several decades.9 Because type 2 diabetes
mellitus is a major cardiovascular disease risk factor, and because
mortality rates from cardiovascular disease are two to four times
higher among adults with type 2 diabetes mellitus,8,9 cardiovascular
disease and type 2 diabetes mellitus may function with other CMD
risk factors to synergistically increase disease burden among
affected populations. Numerous factors influence the CMD risk
of the general population. Non-modifiable risk factors include age,
race/ethnicity, sex, and genetics.1,9 Modifiable factors include sleep
patterns, healthcare access, smoking, dietary choices, and physical
activity patterns.9,14,15 The workplace provides additional modifi-
able risk factors, such as work hours and scheduling, job strain and
stress, and physical exertion.16
Commercial drivers—and in particular, long-haul truck
drivers—face numerous and interrelated CMD risks, and thus exhibit
heightened levels of key CMD risk markers. For example, elevated
levels of hypertension, dyslipidemia, and obesity (as measured by
both body mass index [BMI] and abdominal obesity) have been found
among long-haul truck drivers.17–19 Unique work-related experiences
of long-haul truck drivers exacerbate their CMD risk, such as work
organization and workplace characteristics, including work
hours, shift work, fatigue, job strain, stress, and availability of health
resources.19,20 This unique constellation of CMD risk factors enhan-
ces long-haul truck drivers’ likelihood of developing multiple chronic
health conditions, including type 2 diabetes mellitus, cardiovascular
disease, and other cardiometabolic comorbidities.21,22 These
outcomes generate related comorbidities that can increase accident
risk and reduce commercial drivers’ life expectancies.23
Elucidating CMD risk among US long-haul truck drivers is
needed; however, because no existing epidemiological studies of
long-haul truck drivers have simultaneously collected anthropomet-
ric and biometric data, a comprehensive clinical picture of CMD
risk among long-haul truck drivers in the US is not available. Thus,
our paper has three objectives: (1) to generate for the first time a
CMD risk marker profile for long-haul truck drivers based on
primary data collected; (2) to compare the CMD risk marker profile
for long-haul truck drivers to that of the general US population using
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a national dataset; and (3) to examine relationships between CMD
risk markers and CMD outcomes. To accomplish these three
objectives, we use two datasets. The first dataset consists of a
sample of long-haul truck drivers and is used in pursuit of all three
objectives. The second dataset, which is used in pursuit of objectives
two and three, is the National Health and Nutrition Examination
Survey (NHANES), which consists of a large representative sample
and combines both interviews and physical examinations.24 The
NHANES was selected because of its quality of data, sample size,
and degree of overlap with the long-haul truck driver dataset on key
variables related to CMD risk and outcomes.24 We hypothesized
that: (1) long-haul truck drivers have heightened CMD risk markers
compared with that of the general population; and (2) traditional,
body composition, and inflammatory CMD risk markers of both
long-haul truck drivers and the general US population will be
significantly associated with CMD outcomes.
METHODS
Study Design and Procedures
The study was approved by the Institutional Review Board
(IRB) of the University of North Carolina at Greensboro. A non-
experimental, descriptive, cross-sectional design was employed to
collect survey and biometric data from 262 long-haul truck drivers
over a period of 6 months at a large-size TravelCenters of America
(TA) truckstop located in North Carolina. This location constituted a
representative national truckstop: because of the transient nature
of long-haul trucking, and because of the consistent and high level
of trucking activity at this location, this site was representative of
typical US truckstops. Permission to conduct the study at the
truckstop was requested and granted by the TA Corporate Office.
Field researchers trained in survey and biometric data col-
lection and phlebotomy spent approximately 3 or 4 days each week
at the truckstop in two teams. One team of two to four researchers
remained at the TA truckstop from approximately 6 to 10 pm to
collect survey and biometric data. Signs regarding the study were
posted at strategic locations around the truckstop. Using intercept
techniques, researchers approached drivers and asked screening
questions to assure they were long-haul truck drivers and that they
had an overnight layover at the truckstop. During this conversation,
study details, including the voluntary nature of participation, cash
incentives, and the necessary fasting for blood draw the next
morning, were explained. Those drivers able and willing to return
to the same location between 4 and 8 am the next morning were
enrolled and appointments were made for the following morning.
Enrolled drivers were then asked to sign an informed consent form
and were allowed to use aliases for greater confidentiality and in
some cases anonymity. In this manner, drivers’ biometric measures
were collected and drivers were paid a $10 cash incentive. They
were given appointment cards and told they would receive another
$10 the following morning after the blood draw (along with a small
snack).
Of the 262 long-haul truck drivers that completed ques-
tionnaires and anthropometric measures, 115 long-haul truck
drivers returned for blood draws the following morning. The
second team of one to two certified phlebotomists arrived early
at the truckstop, set up their equipment, and, using a medical
privacy screen and fluorescent lamp, proceeded to collect blood
samples from drivers. Following the blood draws, appointment
cards were collected and incentives and small snacks were given to
drivers. Blood samples were then stored in a portable centrifuge
for delivery to the university laboratory later that morning. With
Type I error set at 0.05 and power at 90%, our sample size was
anticipated to enable us to conduct appropriate statistical analyses,
including examining significant differences among independent
and outcome variables.
Survey and Sample Characteristics
Data for demographic, behavioral, and health status variables
that could potentially be related to CMD risk among long-haul truck
drivers were collected. We developed the Trucker Sleep Disorders
Survey from insights gleaned from other key instruments, relevant
literature, and our previous work with long-haul truck drivers.25–28
Key variables for this study included diabetic status, cardiovascular
problems, prescribed medication use, age, race/ethnicity, and tenure
in the profession. Diabetes diagnosis and cardiovascular health
problem information was provided via self-report.
Anthropometric Measures
Given the high prevalence of overweight and obesity among
long-haul truck drivers, we were interested in identifying simple
anthropometric measures that could be utilized in this group to screen
drivers with the highest risk for long-term health complications. Using
a privacy screen in a low-traffic area of the truckstop, the weight of
each driver was recorded in kilograms to the nearest tenth using an
Elite XXL scale. Height was measured to the nearest centimeter using
a portable stadiometer (Seca, Chino, CA). BMI (kg/m2) was calcu-
lated and rounded to the nearest tenth. Waist circumference was
assessed using a Gulick II tape measure with tension indicator and
SAD measures were taken at the level of the umbilicus [approximat-
ing the L4–L5 level of the spine] using a Rosscraft Campbell caliper
#20 (Vancouver, BC) and values recorded to the nearest tenth of a
centimeter. Each measure was taken two times and averaged.
Blood Pressure
Participants rested quietly for 5 minutes with their arm
supported at heart level and their feet on the floor, as outlined by
the Seventh Report of the Joint National Committee on Prevention,
Detection, Evaluation and Treatment of High Blood Pressure.29
Manual cuff blood pressure measurements were repeated two times
with 5 minutes between measures, and values for systolic and
diastolic blood pressure were averaged from the two measures.
Blood Draws and Specimens
Following occupational safety and health administration pro-
cedures,30 blood was taken from the antecubital space in either arm
using aseptic technique by a certified phlebotomist. Blood was collected
in red top tubes and allowed to clot at room temperature for 15 to
20 minutes. Using a portable centrifuge (LW Scientific E8 Portafuge,
Atlanta, GA), blood samples were spun at 3000 rpm for 15 minutes and
then transported on ice to the laboratory. To limit freeze/thaw cycling,
serum was divided into aliquots and stored at80 8C for future analysis.
We requested that participants fast for 8 hours prior to the
blood draw. Because of the scheduling of long-haul truck drivers,
which are demanding and structured around 10 hours breaks in
between driving shifts,31 we realize that it was not possible for all
participants to fast for the requested 8 hours. Based on the available
literature, which suggests ambiguity in terms of standardized
required fasting periods for our various blood analyes,32 and given
the impracticality of requiring longer fasting periods of the drivers
in our sample, we felt that this fasting time was appropriate. In
comparison, the NHANES sample used for comparisons in this
study only fasted for approximately 6.49 hours.
Blood Analysis
All samples are analyzed in duplicate with appropriate
quality controls in the University’s Exercise Physiology Laboratory
using commercially available ELISA systems and the EPOCH plate
reader (BioTek, Winooski, VT). Specifically, lipid profiles (total
cholesterol, triglycerides, low-density lipoproteins, and high-
density lipoproteins), were assayed using colorimetric reagents
using protocols specified by the manufacturer (Wako USA, Rich-
mond, VA). Glucose was assayed using a colorimetric assay (Kit no.
# 10009582; Caymen Chemical, Ann Arbor, MI). The range of this
assay is 2.5 to 25 mg/dL and all serum samples were diluted 1:5
prior to analysis. Samples above the detection limit of 25 mg/dL
were further diluted and reanalyzed. Tolerance for duplicate sample
variance was set at 15% and samples were re-analyzed if the
coefficient of variance (CV) for the duplicate was greater than 15%.
The National Health and Nutrition Examination
Survey
The NHANES provided an excellent comparison sample to
elucidate the CMD risk of long-haul truck drivers versus the general
US population. The NHANES is collected annually through house-
hold screenings to assess for meeting predetermined criteria for
inclusion and involves both an interview and physical examin-
ation.33 Beginning in 2011, there was no age limit for inclusion,
and the NHANES initiated purposive oversampling of minority
populations, including, Hispanics, African Americans, Asians,
Whites at or below 130% of the federal poverty level, and Whites
80 years of age or older.34 The interview portion includes demo-
graphic, health, and nutrition information, with physical measure-
ments and blood collections including blood and urine specimens
for laboratory testing.33 The final sample for the 2011 to 2012
sample, which was the reference sample for the bulk of our
comparisons included 9338 people.33 Since our long-haul truck
driver sample featured only men 18 and older, we filtered the
NHANES dataset to match these demographic characteristics.
For all comparisons except for high-sensitivity C-reactive protein
(hs-CRP), the NHANES 2011 to 2012 cohort was used, which
included 2820 subjects. Because this cohort did not include hs-CRP
measure, we utilized the data from the 2009 to 2010 cohort, which
included 2561 subjects.
Statistical Analysis
We first performed descriptive analyses to create a profile of the
long-haul truck driver sample in comparison to the NHANES data.
Descriptive statistics included age, job tenure (as years in profession),
race/ethnicity (white vs. non-white), and the use of prescription
medications. Next, we conducted descriptive analyses of CMD
risk for each sample to include traditional (blood pressure; HDL,
low-density lipoprotein (LDL), non-HDL, and total cholesterol;
triglycerides; and blood glucose), body composition (BMI, WC,
and SAD), and inflammatory (hs-CRP) risk markers. We then
recorded the means and standard deviations, along with the sample
size information, to utilize for summary independent-sample t-tests.
These t tests analyzed statistical significance in mean differences
between the two samples. The outcome variables used for further
CMD risk analyses included metabolic syndrome, diabetes, and
cardiovascular health problems (for long-haul truck drivers) or cor-
onary heart disease (for the NHANES cohort) diagnoses. Metabolic
syndrome was diagnosed if subjects met three or more of the five
diagnostic criteria discussed in the introduction (or were prescribed
medication for lipids, BP, or glucose). We then tested for group
differences between the long-haul truck driver and NHANES samples
using chi-squared (x2) tests. Using the CMD risk and outcome
variables, we performed partial correlation analyses for both samples
to compare associations; with these analyses we controlled for
prescription medication use and weighted the data for race/ethnicity
due to the discrepancies in racial make-up of the two samples (51.0%
white in the long-haul truck driver sample vs. 37.1% white in the
NHANES sample). This was most likely to due to the aforementioned
purposive oversampling of minority populations within NHANES. All
statistical analyses were performed using SPSS 23.0.35
RESULTS
While many long-haul truck drivers agreed to participate in
the questionnaire and anthropometric portion of the study, slightly
fewer than half these drivers (N¼ 115, 43.9%) returned the follow-
ing morning for a fasted blood draw. We first performed x2 tests to
assess for non-response bias among the long-haul truck drivers who
did not return for the morning blood draw versus who did return
for the morning blood draw. Three subjects from the non-blood
draw group had missing anthropometric variables and were
excluded from the analysis. We found that there were no statistically
significant differences between the two groups. When comparing
anthropometrics or resting blood pressure, the group that returned
for a blood draw was not significantly different on any variable
compared with the individuals who did not return for a
blood draw the following morning. The drivers who returned
for a blood draw in the morning were slightly older (47.8 vs.
45.7 years old), had slightly larger WC (115 cm vs. 114.6 cm)
and SAD (32.4 cm vs. 32.2 cm), and had slightly higher resting
systolic (129.3 mm Hg vs. 128.5 mm Hg) and diastolic blood pres-
sure (82.8 mm Hg vs. 80.6 mm Hg), but none of these differences
were significant. The drivers who returned for blood draws had
identical BMI (33.4) as those who did not. These comparisons were
similarly reported in a previous study which used the same dataset.36
The long-haul truck driver and NHANES samples were very
similar across several measures (see Table 1). There were no stat-
istically significant differences between the two samples based on
age, years in profession, or the use of prescription medications. The
mean age of the long-haul truck driver sample was 47.8 (standard
deviation [SD]¼ 9.7) and the mean age of the NHANES cohort was
47.9 (SD¼ 18.4). Long-haul truck drivers reported working in the
profession for an average of 14.4 years (SD¼ 11.3), while those in the
NHANES cohort reported working in their respective professions for
an average of 15.1 years (SD¼ 12.9). Sixty-seven percent of the long-
haul truck driver sample reported using prescription medications,
compared with 69.1% of the NHANES sample. There were statisti-
cally significant differences between the two samples based on race/
ethnicity: of the truck driver sample, 51% were whites, compared with
37.1% of the NHANES sample.
The long-haul truck driver sample was significantly higher
than the NHANES sample across most CMD risk markers (Table 2).
Mean differences of 5.79 for BMI (t¼ 7.42, P< 0.01), 23.19 cm for
WC (t¼ 11.38, P< 0.01), and 10.28 cm for SAD (t¼ 21.57,
P< 0.01) were found across the body composition measures, with
the long-haul truck driver sample measuring higher for all three.
With regards to blood pressure, the means of both the systolic and
diastolic readings were significantly greater among the long-haul
truck driver sample, with a mean difference of 8.22 mm Hg for
TABLE 1. Comparison of Demographics and Prescribed
Medication Use of Long-Haul Truck Driver Sample and
NHANES (Filtered) 2011 to 2012 Data
Truck Drivers NHANES P
Age: mean (SD) 47.8 (9.7) 47.9 (18.4) NS
Years in profession: mean (SD) 14.4 (11.3) 15.1 (12.9) NS
Race/Ethnicity
White (%) 51.0 37.1 a
Non-White (%) 49.0 62.9
Prescribed medication use (%) 67.0 69.1 NS
Blood pressure (%) 24.1 —
Cardiovascular health (%) 13.4 11.8
Cholesterol (%) 7.1 —
Diabetes (%) 5.3 3.5
Metabolic (%) — 6.7
NHANES, National Health and Nutrition Examination Survey; NS, not significant;
SD, standard deviation.
aP< 0.01.
systolic (t¼ 4.40, P< 0.01) and 14.73 mm Hg for diastolic
(t¼ 11.54, P< 0.01). The NHANES sample was significantly
higher for HDL cholesterol (M¼ 17.07 mg/dL, t¼ 13.45,
P< 0.01), total cholesterol (M¼ 14.64 mg/dL, t¼ 3.78, P< 0.01),
and blood glucose (M¼ 18.94 mg/dL, t¼ 6.25, P< 0.01). The long-
haul truck driver sample had significantly greater means for trigly-
cerides (M¼ 44.70 mg/dL, t¼ 4.88, P< 0.01) and, as reported in a
previous study using the same dataset,36 for hs-CRP (M¼ 8.47 mg/L,
t¼ 40.52, P< 0.01).
For the three CMD outcome variables (diabetes diagnosis,
metabolic syndrome, and cardiovascular problems) (see Table 2),
18.3% of the long-haul truck driver sample had been diagnosed with
diabetes, compared with only 7% of the NHANES sample. Nearly
74% (73.7%) of the long-haul truck driver sample met the criteria
for metabolic syndrome, versus only 33.8% of the NHANES
sample. There were significant differences between the two samples
for both diabetes diagnosis and meeting the criteria for metabolic
syndrome (P< 0.01 for both). Finally, 4.3% of the long-haul truck
driver sample reported being diagnosed with cardiovascular health
problems, while only 3.6% of the NHANES sample had been
diagnosed with coronary heart disease; however, this was not a
statistically significant difference.
When examining the partial correlations between the three
CMD outcome variables and the CMD risk markers (Table 3), there
were interesting similarities and differences between the two
samples. For diabetes diagnosis, there was little association with
the risk markers within the NHANES sample; however, with the
long-haul truck driver sample there were significant correlations
with measures of WC (r¼ 0.26, P< 0.05), SAD (r¼ 0.24,
P< 0.05), non-HDL cholesterol (r¼0.34, P< 0.05), total cho-
lesterol (r¼0.32, P< 0.05), and diastolic BP (r¼0.41,
P< 0.01). For metabolic syndrome, there were several modest to
relatively strong associations with the CMD risk markers. Statisti-
cally, significant associations for long-haul truck drivers included:
BMI (r¼ 0.32, P< 0.01), WC (r¼ 0.28, P< 0.05), SAD (r¼ 0.35,
P< 0.011), HDL (r¼0.30, P< 0.01), triglycerides (r¼ 0.22,
P< 0.05), systolic blood pressure (r¼ 0.31, P< 0.01), and diastolic
blood pressure (r¼ 0.45, P< 0.01). For the NHANES cohort,
statistically significant associations included BMI (r¼ 0.34,
P< 0.05), WC (r¼ 0.35, P< 0.05), SAD (r¼ 0.36, P< 0.05),
LDL (r¼ 0.37, P< 0.05), glucose (r¼ 0.47, P< 0.01), and trigly-
cerides (r¼ 0.52, P< 0.01). Finally, for the long-haul truck driver
sample, only non-HDL cholesterol (r¼ 0.23, P< 0.05) and total
cholesterol (r¼ 0.23, P< 0.05) held significant correlations with
cardiovascular health problems; similarly, for the NHANES sample,
the only two significant correlations with coronary heart disease
were non-HDL cholesterol (r¼0.14, P< 0.05) and total choles-
terol (r¼0.15, P< 0.05).
DISCUSSION
Heightened CMD risk among long-haul truck drivers has far-
reaching consequences. Among long-haul truck drivers, heightened
CMD risk is associated with excessive daytime sleepiness, disordered
sleep, and workplace fatal and nonfatal injuries.37–40 Cumulatively,
heightened CMD risk contributes to life expectancies approximately
16 years shorter than the general US population.23 The trucking
industry is burdened by excessive healthcare costs and reduced labor
productivity associated with CMD risk and associated outcomes.20
Given the importance of the trucking industry to the US economy,
poor long-haul truck driver health has negative impacts for multiple
stakeholders, such as insurance companies, healthcare systems, man-
ufacturing and warehousing firms, and truckstop companies.20 Fur-
ther, CMD risk has implications for public safety, as factors such as
hypertension, obesity, diabetes, and cardiovascular disease impair key
safe driving abilities required of long-haul truck drivers.20
These findings present a comprehensive clinical picture of
CMD risk among long-haul truck drivers in the US for the first time.
The long-haul truck driver sample presented elevated CMD risk
compared with established normal ranges for CMD risk markers.
On average, the long-haul truck driver sample was pre-hypertensive
(120 to 139 mm Hg systolic; 80 to 89 mm Hg diastolic) and exhibited
undesirable LDL cholesterol (>100 mg/dL), HDL cholesterol
(<60 mg/dL), and triglyceride (>150 mg/dL) levels.41,42 The long-
haul truck driver sample was also, on average, obese (BMI30) and
had risk-indicative adipose tissue distribution (WC >102 cm; SAD
>30 cm).43,44 Finally, and as indicated in a previous study using the
same dataset,36 the mean hs-CRP level in the long-haul truck driver
TABLE 2. Comparisons of Cardiometabolic Risk Markers of
Long-Haul Truck Driver Sample and NHANES (Filtered)
2011 to 2012 Data
CMD Marker Mean (SD) Mean Difference P
BMI
Truck drivers 33.38 (6.70) 5.79 a
NHANES 27.59 (8.26)
Waist circumference (cm)
Truck drivers 115.00 (16.15) 23.19 a
NHANES 91.81 (21.60)
Sagittal diameter (cm)
Truck drivers 32.41 (5.68) 10.28 a
NHANES 22.13 (4.98)
Systolic BP (mm Hg)
Truck drivers 129.32 (19.29) 8.22 a
NHANES 121.10 (19.66)
Diastolic BP (mm Hg)
Truck drivers 82.82 (11.43) 14.73 a
NHANES 68.09 (13.49)
HDL cholesterol (mg/dL)
Truck drivers 35.08 (10.69) 17.07 a
NHANES 52.15 (13.44)
LDL cholesterol (mg/dL)
Truck drivers 113.66 (27.64) 4.98 NS
NHANES 108.68 (35.46)
Non-HDL-cholesterol (mg/dL)
Truck drivers 133.39 (30.49) 2.74 NS
NHANES 130.65 (40.55)
Total cholesterol (mg/dL)
Truck drivers 168.16 (30.21) 14.64 a
NHANES 182.80 (41.08)
Blood glucose (mg/dL)
Truck drivers 86.32 (26.79) 18.94 a
NHANES 105.26 (32.03)
Triglycerides (mg/dL)
Truck drivers 164.12 (91.80) 44.70 a
NHANES 119.42 (96.40)
hs-CRP (mg/L)
Truck drivers 8.83 (9.96) 8.47 a
NHANES (2009–2010) 0.35 (0.78)
Diabetes diagnosisy
Truck drivers 18.3 11.3 a
NHANES 7.0
Metabolic syndromey
Truck drivers 73.7 39.9 a
NHANES 33.8
Cardiovascular health problems/coronary heart diseasey
Truck drivers 4.3 0.7 NS
NHANES 3.6
BP, blood pressure; BMI, body mass index; CMD, cardiometabolic disease;
NHANES, National Health and Nutrition Examination Survey; NS, not significant;
SD, standard deviation.
Used NHANES 2009 to 2010 data for hs-CRP.
yComparisons are expressed in percentages and percentage differences.
aP< 0.01.
sample was far above the normal range (3.0 mg/L), indicating
significant inflammation.45 Long-haul truck drivers from other
countries exhibit similarly elevated CMD risk profiles. For example,
among Brazilian long-haul truck drivers, elevated levels of hyperten-
sion, dyslipidemia, blood glucose, obesity, abdominal obesity, and
metabolic syndrome have been observed compared with established
ranges of CMD risk.21,46 Studies have found elevated BMIs of long-
haul truck drivers in Canada, as compared with a national dataset from
the Canadian Community Health Survey, and in Italy, compared with
bus drivers,47,48 as well as elevated cardiovascular disease outcomes
among long-haul truck drivers in Sweden, matching similar patterns
of other transportation workers.49 Other studies have also shown US
long-haul truck drivers to have elevated levels of metabolic syndrome
and diabetes compared with the US adult working population.17,18
In comparison to the general US population from NHANES,
the long-haul truck driver sample presented elevated CMD risk
markers and had higher diagnosis rates for metabolic syndrome and
diabetes, confirming our first hypothesis. However, there were some
exceptions; namely, total cholesterol and blood glucose levels.
Because of data incompatibilities, it was not possible to detect
whether cholesterol differences are attributable to medication usage
alone. While the long-haul truck driver sample had lower total
cholesterol, measures of LDL and non-HDL cholesterol were
higher, and HDL was lower; thus, their overall cholesterol profile
indicates elevated atherosclerotic,50 and thus elevated cardiometa-
bolic, risk compared with the NHANES sample. Regarding the
lower levels of blood glucose among the long-haul truck driver
sample, drivers who are diagnosed with type 2 diabetes and are
insulin dependent are subject to stringent federal regulations which
require them to apply for a diabetes exemption and mandate that
they exhibit control of their disease51,52; thus, drivers’ livelihoods
are dependent on controlling their glucose levels, and those who are
unable to do so are medically disqualified from the profession. This
highlights the possibility of federal policy to impact CMD risk and
outcomes among long-haul truck drivers. The long-haul truck driver
sample had a slightly greater percentage on diabetes medications,
which may also explain the comparatively lower levels of blood
glucose. The higher diabetes medication use is likely attributable to
the higher diabetes diagnosis rate among the long-haul truck driver
sample, which suggests that screening for diabetes catalyzes efforts
among these individuals to manage their blood glucose levels. Also,
the NHANES fasting times were nearly an hour and a half shorter
than those of the long-haul truck drivers; hence, it is possible that
equivalent fasting times would have negated these differences.
TABLE 3. Partial Correlations for both Long-Haul Truck Drivers Sample and NHANES 2011 to 2012 Data (Controlling for
Prescribed Medication Use and Weighed for Race/Ethnicity)
Analyses Correlation Analyses Correlation
Truck drivers NHANES
Diabetes diagnosis Diabetes diagnosis
BMI 0.21 BMI 0.05
Waist circumference 0.26a Waist circumference 0.08
Sagittal diameter 0.24a Sagittal diameter 0.09
HDL 0.06 HDL 0.11
LDL 0.23 LDL 0.03
Non-HDL cholesterol 0.34a Non-HDL cholesterol 0.06
Total cholesterol 0.32a Total cholesterol 0.10
Glucose 0.00 Glucose 0.02
Triglycerides 0.08 Triglycerides 0.06
Systolic BP 0.05 Systolic BP 0.03
Diastolic BP 0.41b Diastolic BP 0.07
Metabolic syndrome Metabolic syndrome
BMI 0.32b BMI 0.34a
Waist circumference 0.28a Waist Circumference 0.35a
Sagittal diameter 0.35b Sagittal diameter 0.36a
HDL 0.30b HDL 0.17
LDL 0.08 LDL 0.37a
Non-HDL cholesterol 0.15 Non-HDL cholesterol 0.09
Total cholesterol 0.06 Total cholesterol 0.05
Glucose 0.12 Glucose 0.47b
Triglycerides 0.22a Triglycerides 0.52b
Systolic BP 0.31b Systolic BP 0.02
Diastolic BP 0.45b Diastolic BP 0.10
Diagnosed with cardiovascular problems Diagnosed with coronary heart disease
BMI 0.03 BMI 0.04
Waist circumference 0.02 Waist circumference 0.03
Sagittal diameter 0.04 Sagittal diameter 0.03
HDL 0.02 HDL 0.01
LDL 0.05 LDL 0.00
Non-HDL cholesterol 0.23a Non-HDL cholesterol 0.14a
Total cholesterol 0.23a Total cholesterol 0.15a
Glucose 0.07 Glucose 0.10
Triglycerides 0.01 Triglycerides 0.05
Systolic BP 0.02 Systolic BP 0.01
Diastolic BP 0.01 Diastolic BP 0.08
BP, blood pressure; BMI, body mass index; NHANES, National Health and Nutrition Examination Survey.
aP< 0.05.
bP< 0.01.
The overall degree of CMD risk of the long-haul truck drivers
compared with the NHANES sample suggest the powerful influence
of unique occupational characteristics endured by long-haul truck
drivers. Other studies have implicated the role of long work hours,
unpredictable schedules, shift work, job strain, and lack of health-
supportive resources (eg, healthful foods; truck stop gyms) in the
workplace53–56 as factors which induce CMD risk among long-haul
truck drivers. Extant long-haul truck driver health and wellness
programs address these factors rarely, if at all.57 For example, many
long-haul trucking companies provide programs which target one area
of concern, such as Schneider National, Inc. and Gordon Trucking,
Inc., which had programs targeting sleep apnea through screening and
treatment.58,59 Others, such as those provided by JB Hunt, Inc. and
Con-Way Freight, Inc., are more comprehensive; however, even these
focus on individual behavior and fail to address critical elements of
work organization, such as scheduling.58,60 Interventions to curb
excess CMD risk and outcomes among drivers should target these
vital elements of workplace and work organization.
The distinct relationships between CMD risk markers and
CMD outcomes for long-haul truck drivers provide potentially
useful predictive information for clinicians, as unique aspects of
the long-haul trucking profession may differentially induce CMD
risk compared with the general US population. However, while
several significant associations were found, particularly with regard
to metabolic syndrome and cardiovascular disease outcomes, the
unevenness of some of the associations was relatively surprising
with respect to our second hypothesis. One such association is
between glucose and diabetes, which was a nonsignificant but
positive correlation among the long-haul truck drivers. These are
likely partially explained by medication usage, which was relatively
higher among the long-haul truck driver sample compared with the
NHANES sample. Also, as discussed previously, long-haul truck
drivers’ livelihoods are dependent on controlling their glucose
levels, and those who are unable to do so are medically disqualified
from the profession. This may mean that, not only are drivers
especially vigilant in controlling this measure of CMD risk after
being diagnosed with diabetes, but that those that are unsuccessful
in doing so are forced out of the profession through the revocation of
their medical certification.
Other takeaways among the long-haul truck drivers’sample are
the significant associations between CMD risk markers and diabetes
diagnosis, many of which are components of metabolic syndrome. It
appears that metabolic syndrome and diabetes are indeed associated
with similar factors, suggesting the syndemic nature of both diseases.
The pattern of nonsignificance of associations between glucose and
metabolic syndrome further suggests, within the context of the
regulatory environment, the vigilance of drivers in controlling their
glucose levels. In contrast, in the NHANES sample, none of the CMD
risk markers were significantly associated with diabetes diagnosis,
and in fact these risk factors were negatively correlated. This may also
be a function of medication usage, which was nearly 70%. Finally,
there were relatively few significant associations between CMD risk
markers and cardiovascular outcomes. Among the long-haul truck
drivers and NHANES samples, the significance of non-HDL choles-
terol and total cholesterol highlights the importance of these choles-
terol types in arteriosclerosis50 and suggests that these types of
cholesterol may be the most relevant in predicting later cardiovascular
disease outcomes in both populations.7,61
Many of the unexpected patterns of associations between
CMD risk markers and CMD outcomes among our long-haul truck
driver sample are likely influenced by our research design, which is
cross-sectional and represents a ‘‘snapshot’’ in time. To elucidate
the relationship between CMD risk and long-haul truck driver
outcomes, a longitudinal design is required to allow CMD risk
and outcome dynamics to develop over time within a cohort of
drivers. Such a study would also facilitate understanding of the
unique interplay of CMD risk and outcomes within the context of
long-haul trucking. For example, it is possible that CMD outcomes
may be masked in our data by medical examination requirements
imposed on long-haul truck drivers. Federal policy currently dic-
tates that long-haul truck drivers must undergo a screening process
at least once every 2 years.17 As the accumulation of CMD risk
factors manifests as disease states, long-haul truck drivers are
medically disqualified from the profession and thus leave long-haul
truck driving. Should this be the case, our sample—consisting of
medically qualified long-haul truck drivers—may not have captured
the bulk of drivers who are in disease states as a result of a career in a
CMD-inducing occupation. A longitudinal study would also answer
additional, and potentially confounding, questions, such as whether
there is a selection bias among those who choose to enter the long-
haul trucking profession in the first place. It is possible that there is a
subset of the population who finds the default health behaviors—
namely, the consumption of high-fat and high-calorie foods and the
sedentary lifestyle55—of the long-haul truck driving profession
appealing. Such default behaviors are propagated by the lack of
healthful food options and opportunities for exercise at long-haul
truck driver worksites.56 While the medical certification process
likely screens out many of these individuals from entering the
profession, particularly those who exhibit CMD disease states,62
individuals with a propensity toward such behaviors may find these
tendencies exacerbated upon entering the profession, with the array
of CMD risk and outcomes highlighted in the current study being
the result.
There are three primary limitations of the current study. First,
the overall sample size is relatively small, with 262 long-haul truck
drivers, 115 of whom participated in blood draws. While a larger
sample size may have increased our likelihood of finding additional
relationships, the congruency of our findings with other studies
involving long-haul truck drivers indicates that our sample was
highly representative of the population. Second, the potential for
selection bias is an important limitation to consider when interpret-
ing our results. Drivers may have refused to participate for myriad
reasons. For example, giving the increasingly-stringent medical
requirements that drivers must meet to operate a commercial motor
vehicle in the US, drivers may have been concerned that results from
the current study could have potentially resulted in medical dis-
qualification or termination. Drivers may also have been leery of
releasing any personal information to a government entity, including
the University conducting this study. Our own extensive experience
with collecting data from this population has indicated the presence
of a certain level of mistrust among many drivers, and similar
feedback was received from non-participating drivers informally in
the current study as well. These potential selection biases were
discussed in a previous study using the same dataset.36 Third, we
employed a sampling technique that involved blood draws in an
actual long-haul truck driver workplace (at a truckstop). While this
minimized the barriers to participation and likely increased the
willingness of individuals to be involved in the study, it limited the
amount of time drivers were able to fast prior to the blood draw.
Although these shorter fasting times may slightly have altered our
blood values, they are representative of the normal schedules
maintained by these individuals. Further, because the NHANES
sample which was used for comparison had similar or shorter fasting
windows, and because shorter fasting windows generally result in
artificially high readings of many of the CMD risk indicators used
in this study,32 our analyses may in fact underestimate the disparities
in CMD risk between long-haul truck drivers and the general
US population.
In conclusion, this sample of US long-haul truck drivers
presented elevated CMD risk markers, providing a comprehensive
CMD risk marker profile for the first time. Heightened CMD
risk compared with the general US population indicates
occupationally-linked CMD pathogenesis. As the trucking industry
continues to be highly competitive, as the labor pool of commercial
drivers continues to shrink, and as regulatory pressure continues to
increase, measures to reduce the CMD risk of long-haul truck
drivers and its adverse consequences are imperative. These
measures should address unique occupational characteristics experi-
enced by long-haul truck drivers.
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27. Philip P, Åkerstedt T. Transport and industrial safety, how are they affected by
sleepiness and sleep restriction? Sleep Med Rev. 2006;10:347–356.
28. Ursin R, Baste V, Moen BE. Sleep duration and sleep-related problems in
different occupations in the Hordaland Health Study. Scand J Work Environ
Health. 2009;35:193–202.
29. National High Blood Pressure Education Program. Seventh Report of the
Joint National Committee on Prevention, Detection, Evaluation, and Treat-
ment of High Blood Pressure. Bethesda, MD: National Heart, Lung, and
Blood Institute; 2004.
30. United States Department of Labor OSHA. Occupational Safety and
Health Standards. 29 CFR 19101030. United States. Available at: https://
www.osha.gov/pls/oshaweb/owadisp.show_document?p_table=STANDAR
DS&p_id=10051. Accessed April 5, 2016.
31. U.S. Federal Motor Carrier Safety Administration. Summary of Hours-of-
Service Regulations. U.S. Department of Transportation; 2015, Available at:
http://www.fmcsa.dot.gov/rules-regulations/topics/hos/index.htm. Accessed
April 9, 2016.
32. Simundic AM, Cornes M, Grankvist K, et al. Standardization of collection
requirements for fasting samples for the Working Group on Preanalytical
Phase (WG-PA) of the European Federation of Clinical Chemistry and
Laboratory Medicine (EFLM). Clin Chim Acta. 2014;432:33–37.
33. National Center for Health Statistics. National Health and Nutrition Exam-
ination Survey: Sample Design, 2011–2014. Atlanta, GA: Centers for
Disease Control and Prevention, U.S. Department of Health and Human
Services; 2014.
34. National Center for Health Statistics. National Health and Nutrition
Examination Survey: Analytic Guidelines, 2011–2012. Atlanta, GA:
Centers for Disease Control and Prevention, U.S. Department of
Health and Human Services; 2013, Available at: http://www.cdc.gov/nchs/
data/nhanes/analytic_guidelines_11_12.pdf. Accessed April 9, 2016.
35. IBM., Corp. IBM SPSS Statistics for Windows, version 23.0. Armonk, NY:
IBM Corp; 2015.
36. Wideman L, Oberlin DJ, Sönmez S, et al. Obesity indices are predictive of
elevated C-reactive protein in long-haul truck drivers. Am J Ind Med.
2016;59:665–675.
37. Tregear S, Reston J, Schoelles K, et al. Obstructive sleep apnea and risk of
motor vehicle crash: systematic review and meta-analysis. J Clin Sleep Med.
2009;5:573–581.
38. Lemke MK, Apostolopoulos Y. Policy, work organization and sleep health
and safety of commercial drivers: Introducing a complex systems paradigm.
J Ergon. 2016;6:152–156.
39. Moreno CRC, Louzada FM, Teixeira LR, et al. Short sleep is associated with
obesity among truck drivers. Chronobiol Int. 2006;23:1295–1303.
40. Smith SM. Workplace hazards of truck drivers. Mon Labor Rev. 2015;138:
1–5.
41. Centers for Disease Control, Prevention. High Blood Pressure Fact Sheet.
Atlanta, GA: US Centers for Disease Control and Prevention,
Division for Heart Disease and Stroke Prevention; 2015, Available at:
http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_bloodpressure.htm.
Accessed April 9, 2016.
42. Centers for Disease Control and Prevention. Cholesterol Fact Sheet 2015.
Available at: http://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_cho-
lesterol.htm. Accessed April 9, 2016.
43. Centers for Disease Control, Prevention. Assessing Your Weight. Atlanta, GA:
US Centers for Disease Control and Prevention, Division of Nutrition,
Physical Activity, and Obesity; 2015, Available at: http://www.cdc.gov/
healthyweight/assessing/. Accessed April 9, 2016.
44. Riserus U, de Faire U, Berglund L, et al. Sagittal abdominal diameter as a
screening tool in clinical research: cutoffs for cardiometabolic risk. J Obes.
2010;2010:421–437.
45. MedlinePlus. C-Reactive Protein. Bethesda, MD: US National Library of
Medicine, US Department of Health and Human Services, National Institutes
of Health; 2016. Available at: https://www.nlm.nih.gov/medlineplus/ency/
article/003356.htm. Accessed April 10, 2016.
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